We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Wnt signaling in triple-negative breast cancer
PeriodicalsMedical Sciences

Wnt signaling in triple-negative breast cancer

Checking your access to this record.

Abstract & Overview

Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many cancers. An aggressive subtype of breast cancer, known as triple-negative breast cancer (TNBC), demonstrates dysregulation in canonical and non-canonical Wnt signaling. In this review, we summarize regulators of canonical and non-canonical Wnt signaling, as well as Wnt signaling dysfunction that mediates the progression of TNBC. We review the complex molecular nature of TNBC and the emerging therapies that are currently under investigation for the treatment of this disease.

Cite this record

Sebastian Pohl, Naomi Brook, Mark Agostino, Frank Arfuso, Alan Prem Kumar, Arun Dharmarajan (2017). Wnt signaling in triple-negative breast cancer. Oncogenesis, 6(4), e310–e310. https://doi.org/10.1038/oncsis.2017.14

Copy in another style

Pohl, S., Brook, N., Agostino, M., Arfuso, F., Kumar, A. P., & Dharmarajan, A. (2017). Wnt signaling in triple-negative breast cancer. Oncogenesis, 6(4), e310–e310. https://doi.org/10.1038/oncsis.2017.14
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.